Biologics Quality Control Testing

Clinical
Diagnostic

Biologics Quality Control Testing

Clinical
Diagnostic

ABOUT US

PathoQuest, a spin-out of Institut Pasteur Paris, is a genomics expert company offering a game-changing next-generation sequencing (NGS) approach for microbiology testing.

The NGS-based technology the company developed is used for:

• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GLP level

• The diagnosis of infections (including sepsis) based on blood samples

PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.

LATEST NEWS

Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics”

Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics”

The industry needs to bring safer biologics to patient in a more ethical and time effective. Classical viral safety testing approaches often fail to keep pace with the demands faced with new and innovative biomedicines and they have fallen out of favor considering the 3Rs (replacement, reduction, refinement of animal testing). See the calendar in regards with the presentation of the new comparison study between NGS and in vivo.

read more
Meet Olivier Matteudi our new NGS specialist!

Meet Olivier Matteudi our new NGS specialist!

Olivier Matteudi, has over 30 years of experience as a genomic sales engineer and key account manager. Join us to welcome him as he is joining PathoQuest as a Sales Manager and bringing his NGS expertise to the biologics services customers in Europe.

read more
w

Let’s Start Something New

Welcome to PathoQuest!